HEOR

Reshaping the Clinical Laboratory in the Era of Patient-Centered Outcomes, Accountable Care Organizations, and Pharmacogenomics

Reshaping the Clinical Laboratory in the Era of Patient-Centered Outcomes, Accountable Care Organizations, and Pharmacogenomics 150 150 Avalon Health Economics LLC

In recent years there has been renewed attention devoted to coordination of medical care services across the continuum of care, particularly in the area of prevention, monitoring, diagnostics, and disease management. This is not entirely new to the U.S. In the early 1990s, as managed care began to widen its reach and increase market share,…

read more

Health Care Costs and Value: An International Perspective

Health Care Costs and Value: An International Perspective 150 150 Avalon Health Economics LLC

During the recent debates over the Affordable Care Act (“ACA,” or Obamacare) a commonly raised issue was that U.S. health care does not offer much in the way of “value for money.” The argument, generally, is that we spend a lot more in the U.S. relative to comparable countries but in turn receive poor quality…

read more

Using Publicly-Available Health Care Databases to Value & Price Medical Care Services

Using Publicly-Available Health Care Databases to Value & Price Medical Care Services 150 150 Avalon Health Economics LLC

In the United States, a variety of “usual, customary and reasonable” (UCR) databases are used by health care entities to benchmark their fees (in the case of health care providers) and to create prospectively determined fee schedules (in the case of health care payers). Both of these exercises have essentially the same objective: to assign…

read more
Loading...